Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: From atherosclerosis to periodontitis

Journal of Clinical Biochemistry and Nutrition

Volumn 51, Issue 1, 2012, Pages 1-8

  Itabe, Hiroyuki ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Oxidative stress; Oxidized low density lipoprotein; Oxidized phophatidylcholine; Periodontitis

Indexed keywords

ALDEHYDE; BIOLOGICAL MARKER; CARBOXYLIC ACID; ENDOPEROXIDE; EPOXIDE; HYDROPEROXIDE; ISOPROSTANE; KETONE; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYUNSATURATED FATTY ACID;

ACUTE HEART INFARCTION; ATHEROSCLEROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IN VIVO STUDY; INFLAMMATION; NEOPLASM; NONHUMAN; OBESITY; OXIDATIVE STRESS; PERIODONTITIS; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; ULTRACENTRIFUGATION;

MUS;

EID: 84863477494     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.11-00020R1     Document Type: Review

References (62)

1. Stocker R. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevenace. Curr Opin Lipidol 1994; 5: 422-433.
2. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984; 81: 3883-3887. (Pubitemid 14087823)
3. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 1990; 343: 531-535.
4. Greaves DR, Gordon S. Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J Lipid Res 2005; 46: 11-20. (Pubitemid 40066666)
5. Kimura J, Nakagami K, Amanuma K, Ohkuma S, Yoshida Y, Takano T. Monoclonal antibodies recognizing lipid-laden cells and extracellular regions with lipid-deposits in atherosclerotic aorta. Virchows Arch A Pathol Anat Histopathol 1986; 410: 159-164. (Pubitemid 17020551)
6. Mori M, Itabe H, Takatoku K, et al. Presence of phospholipid-neutral lipid complex structures in atherosclerotic lesions as detected by a novel monoclonal antibody. J Biol Chem 1999; 274: 24828-24837.
7. Itabe H, Jimi S, Kamimura S, et al. Appearance of cross linked proteins in human atheroma and rat pre-fibrotic liver detected by a new monoclonal antibody. Biochim Biophys Acta 1998; 1406: 28-39. (Pubitemid 28162308)
8. Itabe H, Takeshima E, Iwasaki H, et al. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholine and polypeptides. J Biol Chem 1994; 269: 15274-15279.
9. Itabe H, Yamamoto H, Imanaka T, et al. Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein. J Biol Chem 1996; 271: 33208-33217. (Pubitemid 27010127)
10. Spiteller G. Peroxyl radicals: inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products. Free Radic Biol Med 2006; 41: 362-387. (Pubitemid 44037278)
11. Ehara S, Ueda M, Naruko T, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001; 103: 1955-1960. (Pubitemid 32322222)
12. Nishi K, Itabe H, Uno M, et al. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol 2002; 22: 1649-1654.
13. Lougheed M, Moore ED, Scriven DR, Steinbrecher UP. Uptake of oxidized LDL by macrophages differs from that of acetyl LDL and leads to expansion of an acidic endolysosomal compartment. Arterioscler Thromb Vasc Biol 1999; 19: 1881-1890. (Pubitemid 29379917)
14. Itabe H, Suzuki K, Tsukamoto Y, et al. Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein. Biochim Biophys Acta 2000; 1487: 233-245.
15. Itabe H, Yamamoto H, Imanaka T, et al. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res 1996; 37: 45-53. (Pubitemid 26052618)
16. Uno M, Kitazato KT, Nishi K, Itabe H, Nagahiro S. Raised plasma oxidised LDL in acute cerebral infarction. J Neurol Neurosurg Psychiatry 2003; 74: 312-316. (Pubitemid 36259353)
17. Itabe H, Ueda M. Measurement of plasma oxidized low-density lipoprotein and its clinical implications. J Atheroscler Thromb 2007; 14: 1-11.
18. Naruko T, Ueda M, Ehara S, et al. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis. Arterioscler Thromb Vasc Biol 2006; 26: 877-883. (Pubitemid 43732166)
19. Itabe H. Oxidized low density lipoprotein: what is understood and what remains to be clarified. Biol Pharm Bull 2003; 26: 1-9. (Pubitemid 39663633)
20. Tsimikas S, Bergmark C, Beyer RW, et al. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 2003; 41: 360-370. (Pubitemid 36164488)
21. Tsimikas S, Lau HK, Han KR, et al. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): shortterm and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 2004; 109: 3164-3170.
22. Fang JC, Kinlay S, Behrendt D, et al. Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation. Arterioscler Thromb Vasc Biol 2002; 22: 2044-2048. (Pubitemid 36025212)
23. Holvoet P, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 2000; 20: 698-702. (Pubitemid 30151683)
24. Holvoet P, Donck J, Landeloos M, et al. Correlation between oxidized low density lipoproteins and von Willebrand factor chronic renal failure. Thromb Haemost 1996; 76: 663-669. (Pubitemid 26388165)
25. Braun S, Ndrepepa G, von Beckerath N, et al. Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting. Am Heart J 2005; 150: 550-556. (Pubitemid 41317628)
26. Velican C, Velican D. The precursors of coronary atherosclerotic plaques in subjects up to 40 years old. Atherosclerosis 1980; 37: 33-46. (Pubitemid 10006856)
27. Meir KS, Leitersdorf E. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 2004; 24: 1006-1014. (Pubitemid 38737824)
28. Kato R, Mori C, Kitazato K, et al. Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2009; 29: 33-39.
29. Tsimikas S, Aikawa M, Miller FJ Jr., et al. Increased plasma oxidized phospholipids: apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression. Arterioscler Thromb Vasc Biol 2007; 27: 175-181. (Pubitemid 46360396)
30. Suzuki M, Kamei M, Itabe H, et al. Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol Vis 2007; 23: 772-778. (Pubitemid 46850583)
31. Akagi M, Kanata S, Mori S, Itabe H, Sawamura T, Hamanishi C. Possible involvement of the oxidized low-density lipoprotein/lectin-like oxidized low-density lipoprotein receptor-1 system in pathogenesis and progression of human osteoarthritis. Osteoarthritis Cartilage 2007; 15: 281-290. (Pubitemid 46238241)
32. Eto M, Yoshikawa H, Fujimura H, et al. The role of CD36 in peripheral nerve remyelination after crush injury. Eur J Neurosci 2003; 17: 2659-2666. (Pubitemid 36819291)
33. Dietrich T, Jimenez M, Krall Kaye EA, Vokonas PS, Garcia RI. Age-dependent associations between chronic periodontitis/edentulism and risk of coronary heart disease. Circulation 2008; 117: 1668-1674. (Pubitemid 351482591)
34. Tonetti MS, D'Aiuto F, Nibali L, et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007; 356: 911-920. (Pubitemid 46339910)
35. Bahekar AA, Singh S, Saha S, Molnar J, Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 2007; 154: 830-837. (Pubitemid 47632489)
36. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000; 71: 1554-1560.
37. Li L, Messas E, Batista EL Jr., Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002; 105: 861-867. (Pubitemid 34174928)
38. Lalla E, Lamster IB, Hofmann MA, et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003; 23: 1405-1411. (Pubitemid 36994529)
39. Delima AJ, van Dyke TE. Origin and function of the cellular components in gingival crevice fluid. Periodontol 2000 2003; 31: 55-76. (Pubitemid 37487410)
40. Pisano E, Cabras T, Montaldo C, et al. Peptides of human gingival crevicular fluid determined by HPLC-ESI-MS. Eur J Oral Sci 2005; 113: 462-468. (Pubitemid 41784331)
41. Sakiyama Y, Kato R, Inoue S, Suzuki K, Itabe H, Yamamoto M. Detection of oxidized low-density lipoproteins in gingival crevicular fluid from dental patients. J Periodontal Res 2010; 45: 216-222.
42. Augé N, Andriew N, Nègre-Salvayre A, Thiers JC, Levade T, Salvayre R. The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induces cell proliferation. J Biol Chem 1996; 271: 19251-19255. (Pubitemid 26271591)
43. Kusuhara M, Chait A, Cader A, Berk BC. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol 1997; 17: 141-148. (Pubitemid 27057336)
44. Hamilton TA, Major JA, Chisolm GM. The effects of oxidized low density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent. J Clin Invest 1995; 95: 2020-2027.
45. Lehr HA, Hübner C, Finckh B, et al. Role of leukotriens in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters. J Clin Invest 1991; 88: 9-14.
46. Higashi Y, Peng T, Du J, et al. A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptor. J Lipid Res 2005; 46: 1266-1277. (Pubitemid 43109841)
47. Ishii H, Kizaki K, Horie S, Kazama M. Oxidized low density lipoprotein reduces thrombomodulin transcription in cultured human endothelial cells through degradation of the lipoprotein in lysosomes. J Biol Chem 1996; 271: 8458-8465. (Pubitemid 26108684)
48. Sata M, Walsh K. Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP. J Biol Chem 1998; 273: 33103-33106. (Pubitemid 29005675)
49. Sanson M, Augé N, Vindis C, et al. Oxidized low-density lipoproteins trigger endoplasmic reticulum stress in vascular cells: prevention by oxygen-regulated protein 150 expression. Circ Res 2009; 104: 328-336.
50. Kelly KJ, Wu P, Patterson CE, Temm C, Dominguez JH. LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes. Am J Physiol Renal Physiol 2008; 294: F1136-F1145.
51. Nagahama Y, Obama T, Usui M, et al. Oxidized low-density lipoprotein-induced periodontal inflammation is associated with the up-regulation of cyclooxygenase-2 and microsomal prostaglandin synthase 1 in human gingival epithelial cells. Biochem Biophys Res Commun 2011; 413: 566-571.
52. Park YM, Febbraio M, Silverstein RL. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 2009; 119: 136-145.
53. Li D, Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 2000; 101: 2889-2895. (Pubitemid 30415877)
54. Tanigawa H, Miura S, Matsuo Y, Fujino M, Sawamura T, Saku K. Dominant-negative Lox-1 blocks homodimerization of wild-type Lox-1- induced cell proliferation through exracellular signal regulated kinase 1/2 activation. Hypertension 2006; 48: 294-300. (Pubitemid 44309826)
55. Miller YI, Viriyakosol S, Worrall DS, Boullier A, Butler S, Witztum JL. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 2005; 25: 1213-1219. (Pubitemid 40776611)
56. Taketa K, Matsumura T, Yano M, et al. Oxidized low density lipoprotein activates peroxisome proliferator-activated recepter-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages. J Biol Chem 2008; 283: 9852-9862.
57. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 1998; 93: 229-240. (Pubitemid 28180856)
58. Inoue M, Itoh H, Tanak T, et al. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-γ. Arterioscler Thromb Vasc Biol 2001; 21: 560-566. (Pubitemid 32323389)
59. Wiesner P, Choi SH, Almazan F, et al. Low dose of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor κB and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia. Circ Res 2010; 107: 56-65.
60. Stewart CR, Stuart LM, Wilkinson K, et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010; 11: 155-161.
61. Wu CC, Wang SH, Kuan II, et al. OxLDL upregulates caveolin-1 expression in macrophages: role for caveolin-1 in the adhesion of oxLDL-treated macrophages to endothelium. J Cell Biochem 2009; 107: 460-472.
62. Suzuki K, Sakiyama Y, Usui M, et al. Oxidized low-density lipoproteins increases IL-8 production in human gingival epithelial cell line Ca9-22. J Periodontal Res 2010; 45: 488-495.